Cargando…
Antibody Content against Epstein–Barr Virus in Blood Extracellular Vesicles Correlates with Disease Activity and Brain Volume in Patients with Relapsing–Remitting Multiple Sclerosis
We aimed to analyze whether EVs carry antibodies against EBV antigens and the possibility that they could serve as diagnostic and disease activity blood biomarkers in RRMS. This was a prospective and observational study including patients with RRMS with active and inactive disease and healthy contro...
Autores principales: | Fernández-Fournier, Mireya, López-Molina, MariPaz, Torres Iglesias, Gabriel, Botella, Lucía, Chamorro, Beatriz, Laso-García, Fernando, Puertas, Inmaculada, Tallón Barranco, Antonio, Otero-Ortega, Laura, Frank-García, Ana, Díez-Tejedor, Exuperio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531815/ https://www.ncbi.nlm.nih.gov/pubmed/37762495 http://dx.doi.org/10.3390/ijms241814192 |
Ejemplares similares
-
Dual role of peripheral B cells in multiple sclerosis: emerging remote players in demyelination and novel diagnostic biomarkers
por: Torres Iglesias, Gabriel, et al.
Publicado: (2023) -
Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2011) -
TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
por: Oreja-Guevara, Celia, et al.
Publicado: (2012) -
Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis
por: Gutiérrez-Fernández, María, et al.
Publicado: (2021) -
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon
por: Fernández-Fournier, Mireya, et al.
Publicado: (2015)